AI filing briefs · archive

8-K filings in August 2024, explained

352 material Form 8-K filings that 310 companies we cover made with the SEC in August 2024, each read and summarized by AI: what happened, the key figures, whether it reads positive or negative for shareholders, and how big a deal it is (impact 1-5). All of them were written later, when past filings were added: a selection, not every 8-K of the month (see the note below).

1 of 352 briefs matches

newest first · times in ET

CYTKCYTOKINETICS INC Aug 15, 4:00 PM ET

Cytokinetics names Brett Pletcher executive VP and chief legal officer, effective Aug. 19

Neutral leadership Written later 5.02

Cytokinetics hired Brett Pletcher as Executive Vice President, Chief Legal Officer, effective August 19, 2024, under an offer letter dated August 13, 2024. The filing sets his $560,000 base salary and a 45% target bonus, along with sign-on and initial equity awards, which are routine terms for a senior executive hire.

Start date is August 19, 2024; base salary is $560,000
Target bonus is 45% of base salary; signing bonus is $100,000
Initial equity awards include RSUs and options each valued at $1,891,620, and PSUs valued at $833,520 at target

Read the filing on SEC.gov ↗

Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.

Briefs marked “Written later” were written in November 2026 for filings that were by then more than three weeks old, so months before mid-October 2026 hold a selection: every material 8-K of the past year for the 100 largest companies we cover and the last 15 important 8-Ks of every other one. Briefs the number check holds back are not shown or counted. Also: the last 45 days, briefs by company, A–Z and the live SEC filings wire.